FDA Approved Generic Drug for Attention Deficit Hyperactivity Disorder (ADHD)
Attention deficit hyperactivity disorder is a brain disorder that is usually marked with an ongoing pattern of inattention and hyperactivity that affects proper functioning and development. The United States Food and Drug Administration has recently approved the first generic version of Atomoxetine (Strattera) drug for the treatment of ADHD (Attention deficit hyperactivity disorder) in children and adults.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer